Results 301 to 310 of about 1,474,812 (347)

Rebuilding the Ladder? Contemporary Contests Over Industrial Policy

Global Policy, EarlyView.
ABSTRACT Does the greater embrace of industrial policy globally signal the emergence of a New Washington Consensus? We show that the multiplication of industrial policies, while consequential, signals neither normalisation nor consensus. Rather, industrial policy is increasingly the object of contestation over norms and practices of state ...
Ilias Alami, Jack Taggart, Tom Chodor
wiley   +1 more source

It's the Politics!—Global Trade Governance Beyond Technocracy

Global Policy, EarlyView.
ABSTRACT The World Trade Organization (WTO) struggles to respond to the growing entanglement of trade and geopolitics. Drawing on existing scholarship and 20 in‐depth interviews with ambassadors and senior trade diplomats conducted in Geneva ahead of the 13th WTO Ministerial 2024, this article reveals a fundamental dilemma at the heart of contemporary ...
Nora Kürzdörfer
wiley   +1 more source

Effectiveness of the 2024-2025 KP.2 COVID-19 vaccines in the United States during long-term follow-up. [PDF]

Nat Commun
Ioannou GN, Berry K, Yan L, Huang Y, Lin HM, Bui D, Hynes DM, Boyko EJ, Ferguson JM, Aslan M, Bajema KL.   +10 more
europepmc   +1 more source

Competitive diplomacy in bargaining and war

American Journal of Political Science, EarlyView.
Abstract War is often viewed as a bargaining problem. However, prior to bargaining, countries can vie for leverage by expending effort on diplomacy. This article presents a dynamic model of conflict where agenda‐setting power is endogenous to pre‐bargaining diplomatic competition.
Joseph J. Ruggiero
wiley   +1 more source

Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines. [PDF]

Nat Commun
Chen W, Tompkins KR, Windsor IW, Martinez LT, Ramos M, Li W, Shrivastava S, Rajput S, Chang JS, Sahasrabudhe P, Fennell KF, McLellan TJ, West GM, Dizon KP, Yam A, Mitra S, Saha S, Sharaf D, McKeen AP, Cadima CI, Muik A, Swanson W, Munoz Moreno R, Mendoza Daroca P, Sahin U, Anderson AS, Wu H, Swanson KA, Modjarrad K.   +28 more
europepmc   +1 more source

Why We Shouldn't Trust Institutions: Critical Theory and the Case for Radical Distrust

Constellations, EarlyView.
Zohreh Khoban
wiley   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter, I. M. Adcock, C. Benito‐Villalvilla, R. Bianchini, L. Bjermer, G. Caramori, L. Cari, K. F. Chung, Z. Diamant, I. Eguiluz‐Gracia, E. F. Knol, M. Jesenak, F. Levi‐Schaffer, G. Nocentini, L. O'Mahony, O. Palomares, F. Redegeld, M. Sokolowska, B. Van Esch, M. Zurlo, C. Stellato   +20 more
wiley   +1 more source

The cost of delivering COVID-19 vaccines in four districts in Malawi. [PDF]

Cost Eff Resour Alloc
Ruisch A, Ntopi S, Mathur I, Conlin M, McCaffrey A, Walker DG, Suharlim C.   +6 more
europepmc   +1 more source

Hypersensitivity to Excipients in Drugs: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT Drugs contain active pharmaceutical ingredients and excipients, compounds which enhance the pharmacokinetics, stability and palatability of the pharmaceutical formulation. While most drug hypersensitivity reactions (DHR) are caused by active ingredients, excipients may also be involved.
Lene H. Garvey, Knut Brockow, Annick Barbaud, Charlotte G. Mortz, Gianfranco Calogiuri, Asli Gelincik, Osman O. Yeğit, Alla Nakonechna, Annette Wagner, Rik Schrijvers, Toon Ieven   +10 more
wiley   +1 more source

A qualitative analysis exploring barriers and enablers to distribution, delivery, and access to COVID-19 vaccines in Botswana. [PDF]

Front Health Serv
Tlhakanelo JT, Ataguba JE, Pagiwa V, Ramabu N, Kadimo K, Muriithi GN, Achala DM, Adote ENA, Mbachu CO, Beshah SA, Masuka N, Nwosu CO, Akazili J, Ifeanyi C, Molosiwa D.   +14 more
europepmc   +1 more source